This content is machine translated Endometrial carcinoma Patients in advanced stages benefit from combination therapy Treatment management for patients with primarily advanced or recurrent endometrial cancer is changing. The potential of dostarlimab, which is particularly effective in patients with mismatch repair deficiency/high microsatellite instability, offers…
